Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 121 results

Efficacy of Dupilumab in Treating Atopic Dermatitis With Recurrent Eczema Herpeticum in a Patient With DOCK8-Deficiency Hyper-IgE Syndrome: A Case Report

research Efficacy of Dupilumab in Treating Atopic Dermatitis With Recurrent Eczema Herpeticum in a Patient With DOCK8-Deficiency Hyper-IgE Syndrome: A Case Report

August 2023 in “Cureus”

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

research Regulatory T Cells: The Many Faces of Foxp3

125 citations , September 2019 in “Journal of Clinical Immunology”

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

research Dupilumab in Inflammatory Skin Diseases: A Systematic Review

72 citations , March 2023 in “Biomolecules”

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

research Index

November 2019 in “Harper's Textbook of Pediatric Dermatology”

The document is a detailed medical reference on skin and genetic disorders.

research British Society for Pediatric Dermatology Annual Meeting, Sheffield, 18-19 November 2016

December 2016 in “British Journal of Dermatology”

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

View more "dock8-deficiency" in research →

Community Join

4 / 4 results

community C’est terrible - at my wits end

in Female 450 upvotes 2 years ago

A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

community My Testosterone is less than 1/3rd In 7 Months since I took Finasteride!

in Finasteride/Dutasteride 116 upvotes 2 years ago

A user experienced a significant drop in testosterone levels after taking finasteride, leading to side effects like low libido and muscle mass loss. Despite its effectiveness for hair, the user decided to stop finasteride due to its impact on hormones, preferring to be bald.

community What makes breezula different than formula 82f?

in Question 9 upvotes 5 years ago

Breezula (clascoterone) and Formula 82F (topical finasteride) are treatments for hair loss that block DHT differently; Breezula competes with DHT at the hormone receptor site without systemic effects, while 82F inhibits the enzyme that converts testosterone to DHT. Breezula may work for those who don't respond to finasteride and vice versa.

community What do we actually know about HMI-115?

in Chat 16 upvotes 2 years ago

The post and conversation are about HMI-115, a potential treatment for hair loss. The conclusion is that HMI-115 is not a 5ar-inhibitor and is instead a prolactin receptor inhibitor. Some users are skeptical about its effectiveness and believe that baldness will still be a problem in the future.